Home
About
Overview
Sharing Data
ORCID
Help
History (25)
A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer.
Comprehending phenotypic plasticity in cancer and evolution.
The DNA walk and its demonstration of deterministic chaos-relevance to genomic alterations in lung cancer.
New challenges in detecting, grading, and staging endometrial cancer after uterine morcellation.
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics.
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics. Semin Cancer Biol. 2022 11; 86(Pt 2):233-246.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Chemokines
Humans
Lung Neoplasms
Prognosis
Tumor Microenvironment
authors with profiles
Ravi Salgia